We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mandatory Part 11 Risk Assessment Could Cost Industry Billions
Mandatory Part 11 Risk Assessment Could Cost Industry Billions
November 3, 2006
The drug, biologics and device industries could face billions in additional costs if the FDA requires risk analysis to be part of electronic recordkeeping regulations, an industry consultant says.